Clinical study offer

🫁 Paid Emphysema Clinical Trials

Browse recruiting emphysema clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Emphysema
Condition

Active Clinical Trials for Emphysema

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Emphysema

Emphysema is a chronic lung condition where the air sacs are progressively damaged, causing shortness of breath and reduced oxygen exchange. Clinical trials explore lung volume reduction techniques, biologic lung sealants, stem cell regeneration, and novel bronchodilator combinations.

Common Symptoms

Shortness of breath especially during exertion, persistent cough with mucus, wheezing, chest tightness, reduced exercise tolerance, unintentional weight loss, fatigue

Risk Factors

Smoking, exposure to secondhand smoke, occupational dust and fumes, air pollution, age, family history, alpha-1 antitrypsin deficiency

Treatment Overview

Treatment includes bronchodilators, inhaled corticosteroids, oxygen therapy, and pulmonary rehabilitation. Clinical trials study biologic lung volume reduction and regenerative therapies.

Why Participate?

Emphysema trials offer access to minimally invasive lung volume reduction and potential regenerative treatments.

Related Conditions

States with Emphysema Clinical Trials

Cities with Emphysema Clinical Trials

Frequently Asked Questions About Emphysema Clinical Trials

Emphysema clinical trials are research studies that test new treatments, medications, devices, or interventions for managing or treating emphysema. They help determine the safety and effectiveness of potential new approaches.
Eligibility varies by study. Factors include the type and severity of emphysema, age, overall health status, and prior treatment history. Each study has specific inclusion and exclusion criteria.
Compensation depends on the study duration, number of visits, and procedures involved. Participants may receive payments ranging from $50 to $300 per visit, with total compensation varying by study.
All clinical trials follow strict safety protocols and are reviewed by Institutional Review Boards (IRBs) to protect participants. Potential risks are explained during the informed consent process before enrollment.